Skip to main content

Advertisement

SpringerLink
Log in

Change in OncomicroRNA Expression in the Placenta during Preeclampsia

  • EXPERIMENTAL METHODS FOR CLINICAL PRACTICE
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

The expression of microRNA-17, microRNA-181a, and microRNA-519a in the villous tree in preeclampsia was analyzed using chromogenic in situ hybridization technique (CISH). It was found that in early-onset preeclampsia, the expression of microRNA-17 in the syncytiotrophoblast was higher (p<0.05) than in late preeclampsia, and the expression of microRNA-519a was higher (p<0.05) than in women with preterm birth at 26-31 weeks gestation. We revealed higher level of expression of microRNA-181a (p<0.05) in the cytoplasm of the syncytiotrophoblast of intermediate placental villi in the group with premature delivery in comparison with early preeclampsia. In full-term pregnancy, the expression of microRNA-181a in the vascular endothelium of placental villi was higher (p<0.02) than in women with premature deliveries. Analysis of the target genes associated with these microRNAs showed that damage to the trophoblast typical of preeclampsia, especially up to 34 weeks gestation, was accompanied by selective activation of genes participating in invasion and compensatory suppression of oncoprotective genes associated with the development of malignant neoplasms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hypertensive Disorders during Pregnancy, Childbirth, and the Postpartum Period. Preeclampsia. Eclampsia. Clinical Recommendations (Treatment Protocol). Moscow, 2016. Russian.

  2. Akter KA, Mansour MA, Hyodo T, Ito S, Hamaguchi M, Senga T. FAM98A is a novel substrate of PRMT1 required for tumor cell migration, invasion, and colony formation. Tumour Biol. 2016;37(4):4531-4539.

    Article  Google Scholar 

  3. Cordeddu V, Di Schiavi E, Pennacchio LA, Ma’ayan A, Sarkozy A, Fodale V, Cecchetti S, Cardinale A, Martin J, Schackwitz W, Lipzen A, Zampino G, Mazzanti L, Digilio MC, Martinelli S, Flex E, Lepri F, Bartholdi D, Kutsche K, Ferrero GB, Anichini C, Selicorni A, Rossi C, Tenconi R, Zenker M, Merlo D, Dallapiccola B, Iyengar R, Bazzicalupo P, Gelb BD, Tartaglia M. Mutation of SHOC2 promotes aberrant protein N-myristoylation and causes Noonan-like syndrome with loose anagen hair. Nat. Genet. 2009;41(9):1022-1026.

    Article  CAS  Google Scholar 

  4. Fukuda T, Kigoshi-Tansho Y, Naganuma T, Kazaana A, Okajima T, Tsuruta F, Chiba T. CACUL1/CAC1 attenuates p53 activity through PML post-translational modification. Biochem. Biophys. Res. Commun. 2017;482(4):863-869.

    Article  CAS  Google Scholar 

  5. Hao XZ, Fan HM. Identification of miRNAs as atherosclerosis biomarkers and functional role of miR-126 in atherosclerosis progression through MAPK signalling pathway. Eur. Rev. Med. Pharmacol. Sci. 2017;21(11):2725-2733.

    PubMed  Google Scholar 

  6. Kruidenier L, Chung CW, Cheng Z, Liddle J, Che K, Joberty G, Bantscheff M, Bountra C, Bridges A, Diallo H, Eberhard D, Hutchinson S, Jones E, Katso R, Leveridge M, Mander PK, Mosley J, Ramirez-Molina C, Rowland P, Schofield CJ, Sheppard RJ, Smith JE, Swales C, Tanner R, Thomas P, Tumber A, Drewes G, Oppermann U, Patel DJ, Lee K, Wilson DM. A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response. Nature. 2012;488:404-408.

    Article  CAS  Google Scholar 

  7. Louwen F, Muschol-Steinmetz C, Reinhard J, Reitter A, Yuan J. A lesson for cancer research: placental microarray gene analysis in preeclampsia. Oncotarget. 2012;3(8):759-773.

    Article  Google Scholar 

  8. Nizyaeva NV, Kulikova GV, Nagovitsyna MN, Khlestova GV, Yushina MN, Baev OR, Shchegolev AI. DAI-1 Receptor Expression in Placenta in Earlyand Late-Onset Preeclampsia. Bull. Exp. Biol. Med. 2017;164(1):109-114.

    Article  CAS  Google Scholar 

  9. Nizyaeva NV, Kulikova GV, Shchyogolev AI, Zemskov VM. The role of microRNA in regulation of the body’s immune responses. Biol. Bull. Rev. 2016;6(6):473-482.

    Article  Google Scholar 

  10. Pongas G, Kim MK, Min DJ, House CD, Jordan E, Caplen N, Chakka S, Ohiri J, Kruhlak MJ, Annunziata C.M. BRD4 facilitates DNA damage response and represses CBX5/Heterochromatin protein 1 (HP1). Oncotarget. 2017;8(31):51,402-51,415.

    Article  Google Scholar 

  11. Roberts JM, Escudero C. The placenta in preeclampsia. Pregnancy Hypertens. 2012;2(2):72-83.

    Article  CAS  Google Scholar 

  12. Wang W, Feng L, Zhang H, Hachy S, Satohisa S, Laurent LC, Parast M, Zheng J, Chen DB. Preeclampsia up-regulates angiogenesis-associated microRNA (i.e, miR-17, -20a, and -20b) that target ephrin-B2 and EPHB4 in human placenta. J. Clin. Endocrinol. Metab. 2012;97(6):E1051-E1059.

    Article  CAS  Google Scholar 

  13. Wang H, Zhang XM, Tomiyoshi G, Nakamura R, Shinmen N, Kuroda H, Kimura R, Mine S, Kamitsukasa I, Wada T, Aotsuka A, Yoshida Y, Kobayashi E, Matsutani T, Iwadate Y, Sugimoto K, Mori M, Uzawa A, Muto M, Kuwabara S, Takemoto M, Kobayashi K, Kawamura H, Ishibashi R, Yokote K, Ohno M, Chen PM, Nishi E, Ono K, Kimura T, Machida T, Takizawa H, Kashiwado K, Shimada H, Ito M, Goto KI, Iwase K, Ashino H, Taira A, Arita E, Takiguchi M, Hiwasa T. Association of serum levels of antibodies against MMP1, CBX1, and CBX5 with transient ischemic attack and cerebral infarction. Oncotarget. 2017;9(5):5600-5613.

    PubMed  PubMed Central  Google Scholar 

  14. Xiao Y, Yu S, Zhu B, Bedoret D, Bu X, Francisco LM, Hua P, Duke-Cohan JS, Umetsu DT, Sharpe AH, DeKruyff RH, Freeman GJ. RGMb is a novel binding partner for PD-L2 and its engagement with PD-L2 promotes respiratory tolerance. J. Exp. Med. 2014;211(5):943-959.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. V. I. Kulakov National Medical Research Center of Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian Federation, Moscow, Russia

    N. V. Nizyaeva, G. V. Kulikova, M. N. Nagovitsyna, N. E. Kan, K. N. Prozorovskaya & A. I. Shchegolev

Authors
  1. N. V. Nizyaeva
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. V. Kulikova
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. N. Nagovitsyna
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. N. E. Kan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K. N. Prozorovskaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. I. Shchegolev
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to N. V. Nizyaeva.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 165, No. 6, pp. 757-761, June, 2018

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nizyaeva, N.V., Kulikova, G.V., Nagovitsyna, M.N. et al. Change in OncomicroRNA Expression in the Placenta during Preeclampsia. Bull Exp Biol Med 165, 793–797 (2018). https://doi.org/10.1007/s10517-018-4267-7

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-018-4267-7

Key Words

Search

Navigation